Cargando…
A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice
There is competing evidence that plasmacytoid dendritic cells (pDC), the most potent source of IFN-I, may initiate psoriasis. We targeted pDC function using the slc15a4(feeble) loss-of-function mouse whose pDC are unresponsive to TLR agonists. slc15a4(feeble) treated with the topical TLR7-agonist im...
Autores principales: | Griffith, Alexis D., Zaidi, Asifa K., Pietro, Ashley, Hadiono, Matthew, Yang, Jessica S., Davis, Rachel, Popkin, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160456/ https://www.ncbi.nlm.nih.gov/pubmed/30262916 http://dx.doi.org/10.1038/s41598-018-32668-9 |
Ejemplares similares
-
Complement C3 Exacerbates Imiquimod-Induced Skin Inflammation and Psoriasiform Dermatitis
por: Giacomassi, Chiara, et al.
Publicado: (2017) -
Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice
por: Li, Fei, et al.
Publicado: (2022) -
2′-Hydroxycinnamaldehyde ameliorates imiquimod-induced psoriasiform inflammation by targeting PKM2-STAT3 signaling in mice
por: Hao, Lihua, et al.
Publicado: (2021) -
Mechanisms and Effects of Isorhamnetin on Imiquimod-Induced Psoriasiform Dermatitis in Mice
por: Wu, Chieh-Shan, et al.
Publicado: (2022) -
Topical application of endothelin receptor a antagonist attenuates imiquimod-induced psoriasiform skin inflammation
por: Nakahara, Takeshi, et al.
Publicado: (2020)